Delaware
|
58-2412516
|
|
(State or other jurisdiction
of incorporation)
|
(IRS Employer
Identification No.)
|
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Exhibit
No.
|
Description
|
|
99.1
|
Press Release dated April 29, 2013
|
Greenway Medical Technologies, Inc. | |||
Date: April 30, 2013
|
By:
|
/s/ William G. Esslinger, Jr. | |
William G. Esslinger, Jr. | |||
Vice President, General Counsel and Secretary
|
Range
($ in millions except
per share data)
|
|
Revenue
|
$132.0 to $134.0
|
Gross profit
|
$68.0 to $70.0
|
Margin
|
51.5% to 52.2%
|
Operating income (loss)
|
($7.0) to ($6.0)
|
GAAP net income (loss)
|
($3.7) to ($3.2)
|
GAAP EPS
|
($0.13) to ($0.11)
|
Adjusted EBITDA
|
$5.8 to $6.8
|
Margin
|
4.4% to 5.1%
|
Bob Kneeley, Vice President, Investor Relations
(678) 390-7262
bobkneeley@greenwaymedical.com
|
XM=) M0K&]E&B,3_$W735M[:'9SH; M'0HX1D:!P*B8I#^7B-S1M5/[Q%32#(=8+6#FU-`FJ+.GE6:6;-C'//BT2M*8 M9W:XU5ZZ+#-&8Y3S`612&^6_K$5G7 G6B_*ALN/&``N&Y5.*(;!DF2N97/YDF2YJ=E,=L+E+#B M-(1?U/2-%CA157P$QO9$XK?D_P!Q"GOGQ1;%C?WYC!A.Y; MXWO8_8`!C_6'[[YANS&$*8IT]JQ+XU\9]I !'FO2;(80:G:2QC>L/BCB-5ZHOZ%15\/@UR'7E)$X>2\9K:O=5C^(D MK:^SN8T7'KXC:9NZT@Y$K'PI-9*H*><6'+$CFEEB=`(T4MAA"3@U%U6R5 M+'WJGU>Q0OY6'!XV[3PE40W,U-P$&+@M5L>HL9"7=.W5[CSR$[JA)).L>5UK M;KU;,'OI:UF]'C:EB#'P".QD)./;I1S151W;3[KPAY-(V^X!\^G[D_*5O:9* M"1]OL^MBC&]A8M%R1WR%TA[OS85\B^S/)', R*T0V,>SNBM1Z^Q.H_Y6=[ M_52*#(]QQE:)@AR6<@,NDRAH-&HCU+84TUIRN:WL\LIAWD5SGO5Q%\^J^-NZ MLRW2.R\RU/G8(,;,,$N3460`K9H[*"*P`,17MBSA-:.2+P,Q4*QJ(JJJ=ORZ MD[F/QX\E,(PW0&>6U+C$O'>3&2Z[Q+5,FER>+;$M+O:=4*YPR-8#BAM('(GT]]9\M')*I84<7.MO%:9[7O6SVG671$5J>*((MSK:>4#.W_4,+QL D^7CDC7273IVRM]3)3))"Q11=@:.;5@"1BM2.:LR'BOE(IJ#5S_62 M40G9/6Y6../WN9_9GQB Q,64;\NK[']>NK TQR/5RK M./<600H*G\8UQ$-&?);VE#9+<'R2'(\(I;VTGFW'7:F4Z;V,E,S-L-?4BO@4 M%J*[K8Q[FCK _P#.EY*>Q5_; MG<_J\$1&?CO%+V(3R57.4O\`8B\58K?%$'ZD A*XH2Y% MM.OLV(!D:8\W'7(8Y48K/L&FQ1<;<17VE8TC6LBE"%A2(9$08_K/@[Q=^/#D MQR_Q"_SK36/X]+QC',B=BDZRR/(XV/#->#K8-M)AP/M!(DQT.#9UQIBC=_\` M'^]%1Z?WK>HH['U]E.J,_P`SUEF]>E7E^!9+ #G]B7D`C$>%)"\VJNH]6E6R%G,:DAQ][FM2Y--;CKV2N_(5YS MQ5RO$G>-]QQ)!\'U=/4_-GN4$94M,\V')DO(J]G:[T;(8)B?DUHS1:*C1R.1 M/-R$AJYKE5J$H;"`C'^U@!DLX.V<7L M)3@L<(RF""L1\AGBX#H_D,E9$C@=O]G%]G+^#`Q.\TM]&//DV5'E$2POJ\), MD9B4QD_'V"9,CGI[Y[H=P)5 HS#'0@RAEFLY98AC[$@2O?9ULHK59Y`8XY6)BD;DB[D;"Y>% M\TUC>V=+65NYLRIY%I(KZ\J67"/`KB+'GSI`XZD^[#YR5,AT`#RM1SFU+Y3Q MC<5H/-[8S;4,)Y)\JYF8Z[PN;K/&MATW[YMB:KV=M?#\)S6DHH];@>QKK"37 MX:4639I$P>>"KJZ^^GBR;)9U5;/NI(J,L?\``),27B$P[^+L6_S'1_U.+UZ` M'$_^&-Q?S2\E_P#5W)NKUZ`ZUUEU%RV4IY+4N5I&BN/F66O?R5X31K.]F>"6 MOFK^2KH+"U!`TM6.O,D NP6\O=K&L*DBO%:MV1(@D: M66)XLC9N1*)5@$9>%(I%5W'(JQ0XF.:'^(&I/Y0^&G^V76'5@7P'MQ-W,7,? MQL<-V1#T;E1L++,<)'CL$RK"0W+:M"$1SK4F/GL.WH&\R4[+I5 )+CE82-,AR)$24(T8Y1/YCH:DAT?U:74]BG]0@PFKK%Z:H"BO- M%%=E#]EG!1;$:L9:[,`JSI&25`Y"GJN63`ZW&8EK^ZCQV=FLR0`J&D1+,G+@ M6!42J"7B)\"14)(VW&C7#^(5AS1Y2\H8^[^5.V]3\BL'W3LEV+ZMH236&KM" M4TO%18-FN+?B,T*P<-E.S"/44CZ^0H944<:?Y2#SI (QM?[.V-@<.8 M>PB83GF7XC%GR1C%)G1L;R"QI@3)`A=Q#/)%":8HQJHV$>YK/THG5I0/G*YW M!J6UQ+;5 ]$:BR7!BVD:C0SNRJK64S8_=SO$#41J-J7RG) M;?,\GR/,,@.R5?97?6^2W ]L)%I9''&CL''CL-,E&(P`!C"%KD&) MC6-:U"/4S/=/,U1Q3:2BS-C.MD\U?S^9R]2>G/?AORQ2T8[, ELA7I'!I?ER1N9"SD\A?@D@EM1VG1ZR2JV4R,3 MVHOFL\U=*L4NRLL2#X+MLVWJG2NXL-X`XCM?:^>:PO7-QFSUC'P6T_9^1F^4 M5.N*2TD8Q.R%:RP;5M+#A)(B,:6ODV11DKZ^6EB>(U:$_G&VSF.< O\FU M^_"*O4F)"J\3LI,P=C*V!3Y/+==_MH"4"."/'IY+F,J850,DXU78U-T.?-;8 M&E5E9#K;GR"\E=T4VEZ7+ GG&DOV7HR8V\DEG%V,:HCM5UB@N5TD,DYD>K==X; M/8?+8^C!;HV+5C`2B?VT6V6AQN/BK2U\D6LS-6:I95YJ -6+R&\ MOX)258>,W+LUW'M)=**_C$MXM(XC;J35CP"T=81ZAP3QC-M#1$,.O<*3'(DM MPE8<3NQ&U;_(3=<;;JIU<[0&$ #=W;,@Q>' M?F)/KX;X$9T Y'C:BH]W9R]EZ.4W/SD1S%H<4QO=5IBT^LPVWG7 M=(S'\7AT!AS["&R!)=(-&*1T@:QV-1@W(B,=W H_E>H.E `R]JC"W-!X MK3X[R97&UIX3W<16G1WFRPO#VV4-]+%)!"-I`E*7O-O$W!3S-L'_``\/\? 8VVE+#'8$S.H-/ M77[LAQZ-D#"1J.1.DP&Q1R2#2,]I;&2I7M[J1%8U>R,_-U.1OR:\IN4^M9.I M]M7&&3F!1X=!I)ZV%*0I8+FSHYGD:)KS/4@D;V(G9%5.W6R=0=*3= M',5H>P+,>?Q*:F9'FTQC\K7EDS&2%VJM',39JI;PQ$<:);L0XZVTA95$9$"F M3*ZHPDF@J6G)>\F3I+ERK28>K=B=[]M;$(KWY,A!/CR%0":6.K.S$@<"(QSD MQ\$?_?#)_P#2N?\`]6Q#K1)K(FC>9VSM9 !Z\S;O+)VQ&3T7U"QFG,5BL1D*4UVHF:MY')1K#$Q MB9&QMG$7:3M*C-:IW:+N\3&.-HG.[._#@J?DK_[\.4'_`+/LO_PU_6EW@MC8 M>3_!;@%:SCC.31&UJW)+%7^I"UYM*MVEAF-@:PJ.4A#Q9.,M9]5_M9#L$.]6 MM%)"W(+MW:>6[NV7F6V,[/!DYAG=R:]R`];"'6P2V!QB$]T6")SAQA>`6(@F M.5$5%7O^?4MN./R6%LDD@KF/]SVJ!Z<=2],Z9ZB:PS^H*V5M:8U.,MRJ4H()+I:; M45+.XUI8);<$`*^S,,^UABBSRK&Q)#@9I/5V'P^JL]D\I#=FP^8%W>"O'&U@ ME\K7R50O&\\<8V[!CE`E.RR.%))##5]KJ1C_`#)=QKY$U#4G)I#DQR3&5"G$ MJ1L6!!WCK6B<]I/6Z1)D$_=5?Q&P"2$C`)X$&\8I#XN-SF7L%-J B,Z M1"O]P9V^G,_Q1SL?KK^948XCD:B-1S**!7#5$[_FW\W/7NY7CXW?)7RHXJ:[ ME:OU-D6,1\5E9);94@LCQ2!D,^-:W4:OC3UC39;VO;&(ZM%+;'(TK4EGEF57 M(=6-@K$LY$:UC7!&AL9<>P#9D;:#^^"=(%);*>VQ$=5^Z&25JI+&9R_88\C2 M*OFJ]8ZJ]5<5K[3.DZ%2O>@S:V3EM:V+%>".M =<2C21.*]94J#7(7G M[RDY+WF/WVP=CV%5(QJI/45D+`"S<'JU#*F.FR)4N!2SA"F6!GJ(3Y9U<1(\ M:.%J-:/]7PY$\ZM_ Y+/&K^KUM(CR<:MXN.1Z[)4**E2CE+8W`#*Z MP_%8XXTJT4P$=*L(<64CAJQ['GM==5=`:FT+D=$XS&ZEK18F/2AT=:O/CY*@ MFP--<7<>7'UQ'+B3>Q\UUIV]_FC;NRQSN:X!7T2U)K33&7TW:T[3J9>):*83 MZ!/9:J\`DQE=:4[/5B"R439JR6#*? 7<:]U3OWZ0>S]BY+MW8F:[0S(T21E>?Y+;Y9D1H$1D"$6WNY MA9TY\6$-7#B@< ()8T MO6YWL3BGO=YK,R5,U;N6DJO"L,*1U!%)M%P]1RUK![&A:6EB\ONH,DW?F,2! M9<-#RLT:36>X99%@R$]B=86C"1A(.#@)Q/(P[^+L6_S'1_U.+UZ`'$_^&-Q? MS2\E_P#5W)NO/_P[^+L6_P`QT?\`4XO7H`<3_P"&-Q?S2\E_]7 9&2>:R,B9;$AE>5*^FEF[K;\I#/_``Z9I7 UZ2HCU1%5HF*[ MQ8='01OTH]+W*EI=2?$[L%O8J(2;[;A^UA4V'C[1\-MSMMZ'-T2T:Q4F3+^# MN0MFD@;?\-PQRD#_`)"NV_C;QLG+;X4N2,+V,K<5VQ
F(5K+;),6W36P7R!1/>F+<79J M?:,PA&"0<'FO(.J.:$JH10M8B-_4K5 B,?)?^(+5 M5R#]CLX/^Q!]-J+XRMN2''>.-E\,#3D''9;TVI@3C`;V4<@H*C?E[#`I$7LH M6V1W, +'(XB/5C7G1US;J7III?"&B:T-V4639,BV;CL!V?;\0O96`@'NMRW))V M78C8[U'F-(X?'&L84L/WC-R$TY(';[7$+VUC('[AWW)/@>1YWX]UQ,H:(Q(< M[;PPV"1_>*.7`K!1/\T?Z4))B7\QHAD>SQ>]HS$&WN[TO5$8[CWG&?`L;A-L M+KDUKB%#<=D9#?L-N:1W,1I'L9ZXFOSE3R:)Z^2L\$\>RN151%.CJJLE5Q=% M[@CQ-200,RIWK&4/\A/ENWD8MR1]_L/'@#SO"K4-.LTX6E`XC)"]R6Y^#^>% MI-]_S_XV]?@@:*T/,B+)D NHXU[$D";X- M>KU\^Z-5K7*TZ.@T-^A8EKPG3V(C!/!WCGS_`#DWV^3]S.2(&&QV[:(OR.ZG MX\626:TKQ1_2Z*?TLR29/D_V\MSR+J#X_H51Y/C[;*#^RSBPY+XI=X4\UWF) ML>328)E ("[@G;^;D?/HU3Q]"T)>=54XE>)CELC;ER)_GF??;8 M`;_C[[GSZ5-+\<>RLDJ675%*OK*`7[#0$928!%> 0X4NRYFUK M#C')E!$Q?`1RM>A?K,1"(,Z.KUT?T1T1G;6$BNKEE3)I7,_8R`C*&6+N,82U M>3CL?"]SN`+]P3Y]67@>G>G *Q7.&YC?:22%O-=JQ_457M:P!)CB":A/T$ M=Z&JPOPD[VC0V>G&=F7,]3N]BE+Q[QF&.*K/TJQ&\@,M,4Z$3LY'*$;F/[HK M'#\2G1U>0_27TK56`EU1R.^SG+5&9=SO\5;%F,[#XCDC';[[G<^K''0_18!' M ]! MH]L:QNA@&1$8[R'+F.:QWDK4)Y`8JJ7X2L^F-8&TUCF]6848;C39?)/50X M\PQ$1Q#HZ (QSRM&"ZQ]Z254$DA50S$^I;I_1.&TU9DLXWO*\J%'5H\ 6?$A'X)%*C49RHY!.XSA>;[`%B?7_V3\_ ` end